TNFRSF12A and gastric adenocarcinoma: Meanwhile, the study also revealed the potential value of TNFRSF12A in the field of STAD immunotherapy, which provides key clues for in-depth investigation of the immunotherapeutic mechanism of STAD and the development of more effective therapeutic strategies.